​

Johnson & Johnson (JNJ) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

JNJ Stock Forecast

Johnson & Johnson (JNJ) stock forecast, based on 34 Wall Street analysts, predicts a 12-month average price target of $162.50, with a high of $166.00 and a low of $159.00. This represents a 5.78% increase from the last price of $153.62.

$140 $146 $152 $158 $164 $170 High: $166 Avg: $162.5 Low: $159 Last Closed Price: $153.62

JNJ Stock Rating

Johnson & Johnson stock's rating consensus is Buy, based on 34 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (50.00%), 14 Hold (41.18%), 3 Sell (8.82%), and 0 Strong Sell (0.00%).

Buy
Total 34 0 3 14 17 Strong Sell Sell Hold Buy Strong Buy

JNJ Price Target Upside V Benchmarks

TypeNameUpside
StockJohnson & Johnson5.78%
SectorHealthcare Stocks 33.91%
IndustryDrug Manufacturers - General Stocks37.84%

Price Target Trends

1M3M12M
# Anlaysts-118
Avg Price Target-$166.00$173.44
Last Closing Price$153.62$153.62$153.62
Upside/Downside-8.06%12.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 252713--22
Mar, 253613--22
Feb, 254711--22
Jan, 254813--25
Dec, 244813--25
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 03, 2025Vamil DivanGuggenheim$166.00$151.879.30%8.06%
Oct 16, 2024Chris ShibutaniGoldman Sachs$159.00$164.28-3.21%3.50%
Oct 16, 2024Terence FlynnMorgan Stanley$175.00$164.106.64%13.92%
Oct 16, 2024Shagun SinghRBC Capital$181.00$164.1010.30%17.82%
Oct 16, 2024Joanne WuenschCitigroup$185.00$164.1012.74%20.43%
Oct 15, 2024Larry BiegelsenWells Fargo$166.00$164.101.16%8.06%
Oct 15, 2024Rick WiseStifel Nicolaus$170.00$164.103.60%10.66%
Oct 15, 2024Joanna WuenschCitigroup$180.00$163.779.91%17.17%
Oct 14, 2024Louise ChenCantor Fitzgerald$215.00$161.6033.04%39.96%
Jul 23, 2024Narumi NakagiriJohnson Rice$150.00$154.24-2.75%-2.36%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 22, 2025Johnson RiceNeutralNeutralhold
Oct 16, 2024Bank of America SecuritiesNeutralNeutralhold
Oct 15, 2024Wells FargoEqual-WeightEqual-Weighthold
Oct 15, 2024BarclaysEqual-WeightEqual-Weighthold
Oct 15, 2024CitigroupBuyBuyhold
Oct 14, 2024Cantor FitzgeraldOverweightOverweighthold
Oct 10, 2024RBC CapitalBuyBuyhold
Oct 08, 2024Goldman SachsNeutralNeutralhold
Oct 08, 2024RBC CapitalOutperformOutperformhold
Sep 06, 2024Johnson RiceOverweightOverweighthold

Financial Forecast

EPS Forecast

$5 $6 $7 $8 $9 $10 $11 $12 $13 $14 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$5.59$7.93$6.86$13.88$5.84-----
Avg Forecast$8.00$9.83$10.05$9.92$9.95$10.57$11.04$11.53$12.21$12.80
High Forecast$8.08$9.94$10.16$9.95$10.09$10.62$11.42$12.49$12.51$13.11
Low Forecast$7.93$9.75$9.96$9.91$9.90$10.51$10.85$10.56$11.99$12.57
Surprise %-30.13%-19.33%-31.74%39.92%-41.31%-----

Revenue Forecast

$60B $70B $80B $90B $100B $110B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$82.58B$78.74B$79.99B$85.16B$61.35B-----
Avg Forecast$81.80B$94.45B$95.02B$84.75B$88.78B$90.30B$93.55B$97.02B$101.93B$106.16B
High Forecast$82.48B$95.24B$95.88B$84.79B$89.21B$91.53B$94.48B$97.31B$103.85B$108.15B
Low Forecast$81.26B$93.83B$94.42B$84.73B$88.58B$89.79B$92.09B$96.74B$100.50B$104.67B
Surprise %0.96%-16.63%-15.82%0.49%-30.89%-----

Net Income Forecast

$10B $16B $22B $28B $34B $40B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$14.71B$20.88B$17.94B$35.15B$14.07B-----
Avg Forecast$15.69B$17.26B$18.98B$13.33B$25.59B$27.05B$28.52B$29.51B$31.26B$32.77B
High Forecast$18.83B$20.71B$22.78B$15.99B$25.83B$27.19B$29.24B$31.98B$32.03B$33.57B
Low Forecast$12.55B$13.81B$15.19B$10.66B$25.35B$26.91B$27.79B$27.05B$30.69B$32.18B
Surprise %-6.21%20.98%-5.49%163.79%-45.03%-----

JNJ Forecast FAQ

Is Johnson & Johnson stock a buy?

Johnson & Johnson stock has a consensus rating of Buy, based on 34 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 14 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Johnson & Johnson is a favorable investment for most analysts.

What is Johnson & Johnson's price target?

Johnson & Johnson's price target, set by 34 Wall Street analysts, averages $162.5 over the next 12 months. The price target range spans from $159 at the low end to $166 at the high end, suggesting a potential 5.78% change from the previous closing price of $153.62.

How does Johnson & Johnson stock forecast compare to its benchmarks?

Johnson & Johnson's stock forecast shows a 5.78% upside, underperforming the average forecast for the healthcare stocks sector (33.91%) and underperforming the drug manufacturers - general stocks industry (37.84%).

What is the breakdown of analyst ratings for Johnson & Johnson over the past three months?

  • April 2025: 9.09% Strong Buy, 31.82% Buy, 59.09% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 13.64% Strong Buy, 27.27% Buy, 59.09% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 18.18% Strong Buy, 31.82% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Johnson & Johnson’s EPS forecast?

Johnson & Johnson's average annual EPS forecast for its fiscal year ending in December 2025 is $10.57, marking a 80.99% increase from the reported $5.84 in 2024. Estimates for the following years are $11.04 in 2026, $11.53 in 2027, $12.21 in 2028, and $12.8 in 2029.

What is Johnson & Johnson’s revenue forecast?

Johnson & Johnson's average annual revenue forecast for its fiscal year ending in December 2025 is $90.3B, reflecting a 47.19% increase from the reported $61.35B in 2024. The forecast for 2026 is $93.55B, followed by $97.02B for 2027, $101.93B for 2028, and $106.16B for 2029.

What is Johnson & Johnson’s net income forecast?

Johnson & Johnson's net income forecast for the fiscal year ending in December 2025 stands at $27.05B, representing an 92.31% increase from the reported $14.07B in 2024. Projections indicate $28.52B in 2026, $29.51B in 2027, $31.26B in 2028, and $32.77B in 2029.